Atom
Product
Blog
Pricing
Webinars
Sign in
Book Demo
Eligibility
Profile
Finance
Other
Similar Grants
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) | Atom
Back
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
Due: Nov 4, 2024
HHS-CDC-HHSCDCERA
$500,000
Description
The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Fund...
Read more
Estimated Total Program Funding
$7,500,000
Expected Number of Awards
8
Award Ceiling
$500,000
Eligible Applicants
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others
- Unrestricted
Additional Eligibility Information
See Section III. Eligibility Information.
Funding Type
Cooperative Agreement
Categories of Funding Activity
- Health
Opportunity Type
Discretionary
Grantor Contact Information
ncipc_erpo@cdc.gov
Other Grantor Informaiton
Candis M. Hunter, PhD, MSPH, REHS<br/>ncipc_erpo@cdc.gov
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
Similar Grants
Studies Addressing Rare Neurodegenerative Diseases including ALS
Rolling Submissions
HHS-FDA
Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life
Rolling Submissions
NASEM
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Due: Sep 5, 2025
HHS-NIH11
$1,838,436